Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Sage Therapeutics, Inc.    SAGE

SAGE THERAPEUTICS, INC.

(SAGE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

10/15/2020 | 09:16am EST

Item 8.01 Other Events.

On October 15, 2020, Sage Therapeutics, Inc. (the "Company") issued a press release announcing interim, topline data from the Company's ongoing Phase 3 open-label SHORELINE study evaluating zuranolone (SAGE-217) in the treatment of patients with major depressive disorder. A copy of the press release is filed as Exhibit 99.1 hereto and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



Exhibit
  No.       Description

99.1          Press release issued by Sage Therapeutics, Inc. on October 15, 2020.


104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about SAGE THERAPEUTICS, INC.
11/05SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition ..
AQ
11/05SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financi..
AQ
11/05SAGE THERAPEUTICS : Announces Third Quarter 2020 Financial Results and Highlight..
BU
11/03SAGE THERAPEUTICS : to Present at Upcoming November Investor Conferences
AQ
11/02SAGE THERAPEUTICS : to Present at Upcoming November Investor Conferences
BU
10/23SAGE THERAPEUTICS : Announces Chief Executive Jeff Jonas to Undergo Scheduled Me..
AQ
10/22SAGE THERAPEUTICS : Announces Chief Executive Jeff Jonas to Undergo Scheduled Me..
BU
10/20SAGE THERAPEUTICS : to Report Third Quarter 2020 Financial Results on Thursday, ..
AQ
10/19SAGE THERAPEUTICS : to Report Third Quarter 2020 Financial Results on Thursday, ..
BU
10/16SAGE THERAPEUTICS : Announces Positive Interim, Topline Zuranolone Safety and To..
AQ
More news